ArticleJournal of hematology2020

Prolonged Remission by Pembrolizumab and Brentuximab-Vedotin Combination Therapy in Heavily-Pretreated Relapsed/Refractory Hodgkin's Lymphoma.

Tsung-Ying Yu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.